These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 37099729

  • 1. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
    Atia O, Friss C, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Matz E, Dotan I, Turner D.
    J Crohns Colitis; 2023 Nov 08; 17(10):1614-1623. PubMed ID: 37099729
    [Abstract] [Full Text] [Related]

  • 2. Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.
    Atia O, Friss C, Focht G, Magen Rimon R, Ledderman N, Greenfeld S, Ben-Tov A, Loewenberg Weisband Y, Matz E, Gorelik Y, Chowers Y, Dotan I, Turner D.
    J Crohns Colitis; 2024 Jan 27; 18(1):38-46. PubMed ID: 37465992
    [Abstract] [Full Text] [Related]

  • 3. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.
    Savelkoul EHJ, Maas MHJ, Bourgonje AR, Crouwel F, Biemans VBC, den Broeder N, Russel MGVM, Römkens TEH, de Boer NK, Dijkstra G, Hoentjen F.
    J Crohns Colitis; 2022 Sep 08; 16(9):1372-1379. PubMed ID: 35303065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries.
    Kante B, Vuyyuru SK, Kedia S, Sahu P, Kumar P, Ranjan MK, Virmani S, Sharma R, Madhusudhan KS, Panwar R, Das P, Makharia G, Ahuja V.
    Indian J Gastroenterol; 2022 Aug 08; 41(4):343-351. PubMed ID: 35997952
    [Abstract] [Full Text] [Related]

  • 10. Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.
    Atia O, Friss C, Focht G, Magen Rimon R, Ledderman N, Ben-Tov A, Loewenberg Weisband Y, Matz E, Gorelik Y, Chowers Y, Dotan I, Turner D.
    Inflamm Bowel Dis; 2024 Nov 04; 30(11):2097-2104. PubMed ID: 38190498
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D, Doveh E, Cohen A, Wilson ML, Grossman AB, Rosh JR, Lu Y, Bousvaros A, Deslandres C, Noble A, Baldassano RN, Levine A, Lerner A, Wilson DC, Griffiths AM.
    Gut; 2015 Dec 04; 64(12):1898-904. PubMed ID: 25416066
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2014 Aug 06; 2014(8):CD003459. PubMed ID: 25099640
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-α: results from the ENEIDA registry.
    Mesonero F, Castro-Poceiro J, Benítez JM, Camps B, Iborra M, López-García A, Torres P, Esteve M, Tosca J, Bertoletti F, Almela P, Calvet X, Vera I, Bujanda L, Gomollón F, Rodríguez C, Antolín B, Busquets D, Hernández A, Rivero M, Monfort I Miquel D, Castaño-García A, Gisbert JP, Domènech E, López-Sanromán A, ENEIDA Project of GETECCU.
    Aliment Pharmacol Ther; 2021 May 12; 53(9):1021-1029. PubMed ID: 33715177
    [Abstract] [Full Text] [Related]

  • 16. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study.
    Jun YK, Ji E, Yang HR, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H.
    Therap Adv Gastroenterol; 2024 May 12; 17():17562848241248321. PubMed ID: 38741927
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC, Hamlin PJ, Greer DP, Warren L, Clark T, Ford AC.
    Aliment Pharmacol Ther; 2012 Jan 12; 35(2):284-91. PubMed ID: 22112005
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
    Suárez Ferrer C, González-Lama Y, González-Partida I, Calvo Moya M, Vera Mendoza I, Matallana Royo V, Arevalo Serrano J, Abreu Garcia L.
    Dig Dis Sci; 2019 Mar 12; 64(3):875-879. PubMed ID: 30542812
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn's disease.
    Fukuchi T, Nakase H, Ubukata S, Matsuura M, Yoshino T, Toyonaga T, Shimazu K, Koga H, Yamashita H, Ito D, Ashida K.
    BMC Gastroenterol; 2014 Jul 11; 13():124. PubMed ID: 25015328
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 11; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.